Pharmaceutical Technology Europe
With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.
Fiona Greer
Advertisement
Articles by Fiona Greer
Advertisement
Latest Updated Articles
Biosimilar Development: 10 Years OnAugust 1st 2014
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5